Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD in Europe
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, reposted from EAHAD on LinkedIn:
”Understanding access to diagnostic tools and treatment options for von Willebrand disease across Europe is essential to improving care and identifying unmet needs.
I encourage all healthcare professionals involved in the diagnosis and treatment of VWD across Europe to take a few minutes to participate in this survey and share their experience.
Your input will help provide a clearer picture of current practice and resource availability across different clinical settings.”
Quoting European Association for Haemophilia and Allied Disorders (EAHAD)‘s post:
”The EAHAD von Willebrand Disease (VWD) Working Group has launched a new survey to assess the availability of diagnostic tools and treatment options across European medical centers.
The aim is to better understand current clinical practice, available resources, and real-world access to care across different settings.
We invite healthcare professionals to contribute their experience and insights.
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026